Draft -- September, 2009. Randomize Agree? Make Patients Aware of Trial Enroll & Start Treatment Screening Consent Discussion Interest ? Eligible? Agree?

Slides:



Advertisements
Similar presentations
MONITORING OF SUBGRANTEES
Advertisements

Every Womans Life PROGRAM MANUAL UPDATE
Recruitment and Retention
How to motivate participation in HES? EHES Training Material.
How to motivate participation in HES. The purpose of recruitment The goal is to achieve as high participation as possible Ensures that the sample represents.
Step by step guide.
The CGEN Project: Development, Implementation and Testing of Genetics Education Materials for Use in Community and Clinical Settings National Coalition.
Presentation Name Recruitment and Accrual of Special Populations Special Population Committee Elizabeth A. Patterson M.D., Chair.
1 Michelle Gerka, Vice-President Family and Community Education –Cicatelli Associates Inc. The Changing Role of the Health Educator June 2, 2009.
Slides produced by the MBR Project Team
Webinar Instructions There will be a question answer session at the END of the webinar. During the presentation please use the Text Chat found on your.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Screen 1 of 24 Reporting Food Security Information Understanding the User’s Information Needs At the end of this lesson you will be able to: define the.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Planning efficient recruitment EHES Training material.
1 Partnership for Health Experience at AIDS Care Roberto B Corales, DO, AAHIVS Medical Director & Principal Investigator September 15, 2011.
SCREENING, REGISTRY, RECRUITMENT Ongoing until recruitment goals met BASELINE ASSESSMENTS DP: Within month before beginning curriculum HH: Within month.
Trying Out New Survey Techniques – Lessons Learned 2013 Northwest Hazardous Materials Management Conference Liz Tennant, Strategic Advisor, Office of the.
For more information, please contact Jonny Andia at 1.
Cultural Sensitivity - Texas Provider Training 2013.
April  Ensure all counselors are familiar with the pros and cons of participation in clinical trials  Ensure all counselors are familiar with.
DCAC ©DCAC 2002 Organizing a Sustainable System of Care for Children with Asthma DC Asthma Coalition Lisa A. Gilmore, Project Director
Cherise Fowler, Outreach and Enrollment Coordinator Alaska Primary Care Association
Staffing ACC's Philosophy  Maintain high Selection Standards –Meet the Business Needs of the Company –Short Term & Long Term  "Promote from within" –Priority.
Preparing for and Disseminating Study Results. Overview This session will cover how to: Develop and implement a dissemination plan Correctly time the.
Step 6: Implementing Change. Implementing Change Our Roadmap.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
1 Targeted Strategies to Improve Physician and Patient Access to Cancer Clinical Research An Overview of Coalition Programs and Services Ruth Lambersky.
Latin American Women’s Right Service Focus Group Findings 17 th December 2013.
C. CRANDALL R. MANDLER M. BOGENSCHUTZ D.DONOVAN L. WORTH R. LINDBLAD Recruitment & Retention SMART-ED, NIDA CTN 0047.
Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
Preparing and Budgeting for Communications. Overview This session will cover how to: Perform a “desk review” Conduct an environmental scan Develop a communications.
Systematic Reviews.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Participant Accrual. Numbers that Matter 3476= total number of women enrolled at least 95% retention at each visit, at each study site 100% attention.
University of Leeds Ethnicity and Cultural Diversity Network The Globe Centre, Accrington 22 nd September 2005.
Monitoring PATH Providers PATH 2010 Grantee Meeting Washington DC December 7-10, 2010 Creating Effective PATH Programs in the Era of Health Reform Robert.
1. Why do patients participate in clinical trials? 2. Overview of I-SPY2: Interacting with patients 3. Helping patients decide whether or not to participate.
Module 3: Informed Consent. This training session contains information regarding: Documenting consent Documenting consent Conducting informed consent.
ASA Online Official Document ver 1.0 Strategic Partner Program We are looking for Strategic Partners to help us advance the ASA Online program worldwide.
Module 5: Data Collection. This training session contains information regarding: Audit Cycle Begins Audit Cycle Begins Questionnaire Administration Questionnaire.
Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Reducing Health Disparities Through Navigation to Mammography Screening Worcester County, Massassachusetts.
Module 3. Session Clinical Audit Prepared by J Moorman.
DODAC and DSaRM Advisory Committee August 1, 2007 Pregnancy Registry and Root Cause Analysis Cynthia Kornegay, Ph.D. Division of Drug Risk Evaluation Office.
How Bishop Feehan Dramatically Improved Matching Gifts HEPdata.
Identifying and recruiting patients for clinical trials in the future: a pharma perspective Rob Thwaites EC/EFPIA Workshop on ” Primary and secondary use.
Consultants attitudes to consumer involvement in clinical research Rachel Thompson, Alan Horwich, Jim Laxton, Joe Flaherty, Andy Norman, Barbara Pearce,
Recruitment and Retention Strategies. Recruitment Strategies.
AccrualNet: A New NCI Tool for Supporting Accrual to Clinical Trials Linda Parreco, RN, MS NCI, Office of Communication and Education September 29, 2010.
Colleen Brody, Program Supervisor II Pristeen Rickett, Disease Intervention Specialist Elizabeth “Page” Brockwell, Service Chief.
NCCCP Pilot – Clinical Trials Ann O’Mara, PhD, RN, FAAN Program Director Community Clinical Oncology Program Division of Cancer Prevention June 26, 2007.
3CTN “Ask Me” Campaign Training Slides. Introduction 3CTN Ask Me Campaign Training Slides March CTN Objectives 1. To improve patient access to.
Patient Recruitment One Size Does Not Fit Most Julie Ross, Senior VP, Global Strategic Services The information contained in this communication is confidential.
Performing a Successful Supportive Care Clinical Trial Jennifer Temel, MD.
Karen Cheung, MPH, Pamela Luna, DrPH, MST, Sarah Merkle, MPH American Evaluation Association Annual Meeting November 11, 2009 The findings and conclusions.
Making Clinical Trials More Efficient Site Management Organization (SMO)
Effectiveness of Patient Navigation on Diagnostic Interval, Anxiety, and Satisfaction of Minority Women with Abnormal Mammograms: a Randomized Controlled.
1 Communication Activities Grant holder's Meeting, December 2011, Brussels.
Exploitation means to use and benefit from something. For Erasmus+ this means maximising the potential of the funded activities, so that the results are.
Impact assessments. Today is; Overview of impact assessment process How this relates to us as healthcare providers & employers & your service.
MTN-025/HOPE Decliner Population Procedures. Who are the Decliner Population? Former ASPIRE participants who decline or express no interest in joining.
Remote Site Initiation Visits
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
DUTIES OF A GENERAL COMMITTEE MEMBERSHIP VICE-CHAIR
Planning efficient recruitment
MTN 037 Recruitment and Retention
Participant Retention
TRTO (Translational Research Trials Office)
Presentation transcript:

Draft -- September, 2009

Randomize Agree? Make Patients Aware of Trial Enroll & Start Treatment Screening Consent Discussion Interest ? Eligible? Agree? Done Treatment Consent Discussion Yes No Yes No Yes No Non-Eligibility Letter Decline Questionnaire I-SPY2 Patient Portfolio Decline Questionnaire Optional Peer Support Call Peer Support Call (s) Done? Congratu- tions Letter No Yes Welcome Letter I-SPY2 Brochure Exit Interview Dropped Out No I-SPY2 Patient Website

Recruitment Promotion Consenting Patients Overall Recruitment Expectations Diversity Considerations Tracking Accrual Patient Decline Questionnaire Retention Patient Materials/Website Network of Strength Hotline Site Specific Support Exit Questionnaire

Trial Site Education Sessions, especially with surgeons Advocacy and Clinical Trials Websites Educational Sessions and Materials for Breast Cancer Hotlines National Scientific and Advocacy Education Sessions Local and National Press Release Local and National Press, TV, & Radio Interviews Local and National Advocate Presentations Scientific and Patient Publications Broad Distribution of I-SPY2 Brochure

See draft brochure

Informed Consent documents have undergone careful review by a large number of experienced advocates Training will be developed to reinforce best practices in consenting and summarize I-SPY2 specific information FAQ questions will be made available to consenters Patient website will have fact sheets, patient schedules, and other relevant information available as PDFs to support consenting process

Goal: Summing over trial sites, I-SPY2 patients should reflect the diversity of US women affected by breast cancer Actions: Travel reimbursement for research visits Proactive recruitment of trial sites that over represent minorities Identify potential affiliate and/or satellite hospitals that might partner with main I-SPY2 sites Proactive recruitment of patients from under represented minorities Targeted advocacy organizations (e.g., ICC) Targeted community outreach Targeted publications

Actions Continued: Develop and deliver culturally sensitive and targeted workshops on participation in clinical trials in general and I-SPY2 in particular Ensure that all of our patient materials are culturally sensitive and include pictures that reflect diverse populations Translate the Informed Consent and Recruiting Brochure into Spanish and/or other languages Identify language translation services that are available at each site Identify potential affiliate and/or satellite hospitals that might partner with main I-SPY2 sites

Quarterly by Trial Site Which sites are exceeding expectations? What can we learn from them? Which sites are failing to meet expectations? How can we remedy this? Quarterly by Patient Biomarker Profile and Treatment Plan Bi-annually for adequate diversity

ProblemPotential Solution Too few patients are offered trial Educate clinicians at trial sites Recruit more trial sites Increase national publicity Too many patients decline screening consent Educate consenters Improve patient material Assess reasons for decline Too many patients decline treatment consent Educate consenters Improve patient material Assess reasons for decline Look for variation by treatment arm

ProblemPotential Solution Distribution of patients by biomarker profile does not reflect distribution in population Identify competing trials for specific profiles at specific sites Over recruit from other sites Distribution of patients declining treatment varies by treatment assignment Clarify whether the issue is based on rejecting standard of care or a particular investigational agent Consider over recruiting controls and/or dropping problematic investigational agents Inadequate diversity Recruit sites in more diverse communities Increase targeted promotion

See draft Decline Questionnaire

Recruitment Promotion Consenting Patients Overall Recruitment Expectations Diversity Considerations Tracking Patient Decline Questionnaire Retention Patient Materials/Website Network of Strength Hotline Site Specific Support Exit Questionnaire

Recruiting Brochure New Patient Portfolio Website PDFs Fact Sheets Patient Schedule Trial Site Map, Support Services, Contact Information Peer to Peer Letters

The right amount of the right information at the right time Easy to navigate Attractivewhite space, pictures Text and FAQs PDF of key pages for use by trial site staff

See Prototype

24x7 toll free hotline Staffed by trained and certified breast cancer survivors Free to callers Spanish speaking counselors Interpretation available in over 150 languages option Match programs Patient specific requests (e.g., diagnosis, treatment, demographics) Male breast cancer matches Partners match program

Screening and Treatment Informed Consent Forms request permission for Network of Strength counselor to call patient Patient may, alternatively, take number and call if and when they please A select group of experiences counselors will be specifically trained about I-SPY2 (based on I-SPY2 Website) Supporting, but not pressuring patients, who are considering enrollment Checking in on, encouraging, and supporting patients who are undergoing treatment

Website will provide site specific information Maps Hospital investigators and contact information Hospital services and contact information Locally available advocacy and support groups Encourage all sites to maintain regular communication with patients and continuous express appreciation for participations in I- SPY2 Optionally, local advocates will be identified to work with investigators at specific trial sites

Finalized Recruiting Brochure Develop detailed PR plan and pieces Develop training for consenters Reassess accrual assumptions Obtain site-specific recruitment, accrual, and diversity expectations Finalize tracking reports and data collection plan Finalize data collection and analysis plans for patient declines

Ensure conformance of Informed Consent documents and plan Hot-line support Decline questionnaire Follow-up on Patient Website Finalize material Construct site Pilot test with advocates Follow-up on Hot-line Finalize budget Negotiate terms Select counselors Develop and deliver training Develop Site Specific Support information